Multiple Sclerosis (MS) Drug Market

RECENT NEWS
FierceBiotech  May 26  Comment 
Missing a secondary endpoint in the RADIANCE trial won't hinder the launch or commercial success of ozanimod, CFO Peter Kellogg tells Barclays analysts.
FiercePharma  May 24  Comment 
Roche’s new drug Ocrevus has landed in the same sentence with the three letters all makers of multiple sclerosis drugs dread: PML.
MarketWatch  May 22  Comment 
Celgene Corp. shares rose about 1% premarket before surrendering their gains, after the company reported positive results from a late-stage trial of a treatment for multiple sclerosis. Celgene said the phase III trial of ozanimod, an...
GenEng News  May 9  Comment 
Nashville-based specialty diagnostic technology company IQuity says it will begin taking orders from enrolled physicians for IsolateMS, reportedly the first RNA-based diagnostic test for multiple sclerosis (MS), in late May. The product...
FierceBiotech  May 8  Comment 
Teva, Active Biotech chalk up another phase 3 failure for once-hyped Copaxone heir laquinimod in multiple sclerosis nptaylor Mon, 05/08/2017 - 04:30
NPR  Apr 30  Comment 
Brandie Jefferson volunteered for a clinical trial to see if intermittent fasting can help treat multiple sclerosis. Five months in, she realizes that this study won't answer that question.
Motley Fool  Apr 25  Comment 
An analyst initiation and upcoming data sends shares of the biotech higher.
MarketWatch  Apr 20  Comment 
Atara Biotherapeutics Inc. shares climbed in the extended session Thursday after the biotech drug developer reported positive results from an early stage clinical trial of its multiple sclerosis drug. Atara shares rose 8.7% to $20.55 after hours....
Forbes  Apr 20  Comment 
Diagnosed with multiple sclerosis in 2000, he set out to find the safest, most effective form of medicinal cannabis for treating his disease and others, and bring that product to the masses.
New York Times  Apr 5  Comment 
Bryan Bickell returned to the N.H.L. after five months, and is believed to be the third person to play in the N.H.L. with multiple sclerosis.




 
TOP CONTRIBUTORS

Very nice site!

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki